FDA Approved A Psilocybin Drug Trial For Depression

 

The FDA has approved a drug trial using psilocybin, the psychoactive ingredient in magic mushrooms. They gave Compass Pathways the go-ahead to perform clinical trials using it on patients with treatment-resistant depression.